Perrigo announces acquisition of Laboratorios Diba for $25 million
ALLEGAN, Mich. An American generic drug maker has acquired a Mexican manufacturer of store-brand OTC and prescription drugs.
Perrigo announced Tuesday that it had bought Guadalajara, Mexico-based Laboratorios Diba for $25 million in cash. The Allegan, Mich.-based Perrigo expects the acquisition to add $15 million to annual sales.
“Perrigo has been in the Mexican market for more than 65 years and is the leading supplier of prescription and OTC store-brand products there,” Perrigo chairman and chief executive officer Joseph Papa said in a statement. “The acquisition of Laboratorios Diba will enable us to market an additional 150 formulas and 50 trademarks into the rapidly growing Mexican store-brand market, saving consumers money on their healthcare options.”
The purchase of the Mexican company follows Perrigo’s September acquisition of Holland, Mich.-based JB Laboratories.
Data shows use of Alli could also impact household members’ habits
PHOENIX and PITTSBURGH New data released during proceedings at this year’s Scientific Meeting of The Obesity Society said that people taking FDA-approved weight-loss pill Alli also tend to make healthier grocery shopping decisions, a trend that is positively influencing families.
A 26-week study reviewed the shopping habits of 15,156 households in which one or more members were taking Alli. The study showed that shoppers in these households were also purchasing items such as cereals, diet control bars, multi-vitamins and yogurt, among other “healthy” options.
Study co-author, Rebecca Reeves, of Baylor College of Medicine, said, “What is so unique and exciting about the data in this abstract is the evidence that people taking Alli made changes in their purchase patterns toward healthier foods. These data show that households purchasing Alli more than once increased their buying of healthier products compared to the previous year.”
The National Institutes of Health have reported that about 65 percent of U.S. adults are obese or overweight. Persons dealing with too much weight are more likely to face health problems such as heart disease, hypertension and type 2 diabetes, the National Institutes said.
Taking Alli, combined with a low-calorie, encourages healthy, modest weight-loss, maker GlaxoSmithKline has said.
Nicotine gum helps pregnant women decrease amount of smoking, research says
WASHINGTON Although nicotine gum does not necessarily increase quit rates among pregnant women, the non-prescription smoking cessation product does help reduce the amount of smoking to the point that use of nicotine gum increased birth weight and gestational age, two key parameters in predicting neonatal wellbeing, new research published last week in the journal Obstetrics & Gynecology has found.
The study tracked pregnant women who smoked daily and received individualized behavioral counseling and random assignment to a 6-week treatment with 2-mg nicotine gum or placebo followed by a 6-week taper period. Women who did not quit smoking were instructed to reduce the number of cigarettes smoked by substituting with gum.
Using a completer analysis, nicotine gum significantly reduced the number of cigarettes smoked per day and cotinine concentration. Birth weights were significantly greater with nicotine gum compared with placebo. Gestational age was also greater with nicotine-replacement therapy than with placebo, the research found.